PROSPECT OF UTILIZING EXPIRED HOMOLOGOUS PLATELET CONCENTRATES AS AN ALTERNATIVE SOURCE OF GROWTH FACTORS AND CYTOKINES IN CLINICAL SETUP FOR BETTER WOUND CARE AND HEALING
DOI:
https://doi.org/10.22159/ajpcr.2024.v17i2.49138Keywords:
Human platelet lysates (hPL), Growth Factors, Long-term Preservation, Wound Healing, Immunohistochemistry (IHC), Ki-67, P63, CD-71, Regenerative MedicineAbstract
Objectives: The purposes of this study were: (1) To evaluate the possibility of preparation of human platelet lysate (hPL) from expired platelet concentrate, its storage – qualitative assessment in terms of growth factor content between freshly prepared hPL and preserved hPL (in liquid nitrogen for up to 6 months) and (2) to evaluate regenerative potential of the stored hPL on the 2° burn wound as compared to standard topical treatment for burns (1% silver sulfadiazine [SSD]).
Methods: hPL was prepared by three rounds of freeze-thaw cycle; concentration of growth factors was estimated by enzyme-linked immunosorbent assay method and compared between fresh hPL and stored hPL. For clinical assessment, patients with 2° burn injury were randomly allocated to SSD and hPL treatment group. Wound status was compared on 3rd week by clinical assessments and based on histopathological findings. Immunohistochemistry was performed using cell proliferative markers to corroborate the extent of healing with the number of proliferating cells that give strong positive reactions to the markers.
Results: Concentration of growth factors in tested samples (hPL fresh - <72 h, hPL-3 month and hPL-6 month) was almost same. No significant decrease in concentration was observed in any of the tested growth factor up to 6 months. p-values (analysis of variance) for concentration variations of platelet-derived growth factor-AA, basic-fibroblast growth factor,and transforming growth factor beta were 0.8981, 0.6417, and 0.9540, respectively. Healing of 2° deep-dermal burns was better for hPL group than SSD treatment at 3rd week and the observed tissue regeneration pattern was corroborated well with the expression of cell proliferative markers.
Conclusion: Our findings suggest that hPL produced from expired platelet concentrates can be used as a potential source of biological factors that could serve its therapeutic need in the field of regenerative medicine, while on the other hand avoiding the waste of valuable human physiological resources.
Downloads
References
Saluja K, Thakral B, Marwaha N, Sharma RR. Platelet audit: Assessment and utilization of this precious resource from a tertiary care hospital. Asian J Transfus Sci 2007;1:8-11. doi: 10.4103/0973- 6247.28066, PMID 21938226
Dunbar NM. Modern solutions and future challenges for platelet inventory management. Transfusion 2015;55:2053-6. doi: 10.1111/ trf.13192, PMID 26372912
Veihola M, Aroviita P, Linna M, Sintonen H, Kekomäki R. Variation of platelet production and discard rates in 17 blood centers representing 10 European countries from 2000 to 2002. Transfusion 2006;46:991-5. doi: 10.1111/j.1537-2995.2006.00832.x, PMID 16734816
Verma A, Agarwal P. Platelet utilization in the developing world: Strategies to optimize platelet transfusion practices. Transfus Apher Sci 2009;41:145-9. doi: 10.1016/j.transci.2009.07.005, PMID 19716339
Dessels C, Durandt C, Pepper MS. Comparison of human platelet lysate alternatives using expired and freshly isolated platelet concentrates for adipose-derived stromal cell expansion. Platelets 2019;30:356-67.
Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE. Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PLoS One 2013;8:e68984.
Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: A review. J Extra Corpor Technol 2006;38:174-87. doi: 10.1051/ject/200638174, PMID 16921694
Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96. doi: 10.1016/j.joms.2003.12.003, PMID 15085519
Cozma CN, Raducu L, Jecan CR. Platelet rich plasma- mechanism of action and clinical applications. J Clin Invest Surg 2016;1:41-6.
Kon E, Filardo G, Di Matteo B, Marcacci M. PRP for the treatment of cartilage pathology. Open Orthop J 2013;7:120-8. doi: 10.2174/1874325001307010120, PMID 23730375
Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet lysate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 2001;24:483-8. doi: 10.2337/diacare.24.3.483, PMID 11289472
Man D, Plosker H, Winland-Brown JE. The use of autologous platelet-rich plasma (platelet gel) and autologous platelet-poor plasma (fibrin glue) in cosmetic surgery. Plast Reconstr Surg 2001;107:229-37; discussion 238-9. doi: 10.1097/00006534-200101000-00037, PMID 11176628
Gkini MA, Kouskoukis AE, Tripsianis G, Rigopoulos D, Kouskoukis K. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7:213- 9. doi: 10.4103/0974-2077.150743, PMID 25722600
Senet P, Bon FX, Benbunan M, Bussel A, Traineau R, Calvo F, et al. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 2003;38:1342-8. doi: 10.1016/s0741-5214(03)00908-x, PMID 14681639
Jo CH, Kim JE, Yoon KS, Shin S. Platelet-rich plasma stimulates cell proliferation and enhances matrix gene expression and synthesis in tenocytes from human rotator cuff tendons with degenerative tears. Am J Sports Med 2012;40:1035-45. doi: 10.1177/0363546512437525, PMID 22366517
Zhang N, Wu YP, Qian SJ, Teng C, Chen S, Li H. Research progress in the mechanism of effect of PRP in bone deficiency healing. Sci World J 2013;2013:134582.
Kon E, Filardo G, Delcogliano M, Fini M, Salamanna F, Giavaresi G, et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 2010;11:220. doi: 10.1186/1471- 2474-11-220, PMID 20875101
Schallmoser RH, Burnouf T, Koh MB. Committee report on cellular therapies of the International Society of Blood Transfusion (ISBT), Zurich, Switzerland. Human platelet lysate current standards and future developments. Transfusion 2019;59:1407-13.
Intini G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 2009;30:4956-66. doi: 10.1016/j. biomaterials.2009.05.055, PMID 19573909
Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg 2005;16:1043-54. doi: 10.1097/01. scs.0000186454.07097.bf, PMID 16327552
Petrungaro PS. Using platelet-rich plasma to accelerate soft tissue maturation in esthetic periodontal surgery. Compend Contin Educ Dent 2001;22:729-46. PMID 11692397
Zhang ZY, Huang AW, Fan JJ, Wei K, Jin D, Chen B, et al. The potential use of allogeneic platelet-rich plasma for large bone defect treatment: Immunogenicity and defect healing efficacy. Cell Transplant 2013;22:175-87. doi: 10.3727/096368912X653183, PMID 22863146
Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, et al. International forum on GMP-grade human platelet lysate for cell propagation: Summary. Vox Sang 2018;113:80-7. doi: 10.1111/vox.12593, PMID 29076169
Singh RP, Marwaha N, Malhotra P, Dash S. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci 2009;3:86-94. doi: 10.4103/0973-6247.53882
Cécile A, Flint AW, Ozier Y, McQuilten Z. Platelet storage duration and its clinical and transfusion outcomes: A systematic review. Crit Care 2018;22:185.
Egidi MG, D’Alessandro A, Mandarello G, Zolla L. Troubleshooting in platelet storage temperature and new perspectives through proteomics. Blood Transfus 2010;8:S73-81.
Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, et al. The clearance mechanism of chilled blood platelets. Cell 2003;112:87-97. doi: 10.1016/s0092-8674(02)01253-9, PMID 12526796
Altaie A, Owston H, Jones E. Use of platelet lysate for bone regeneration-are we ready for clinical translation? World J Stem Cells 2016;8:47-55. doi: 10.4252/wjsc.v8.i2.47
Ramírez-Santana C, Pérez-Cano FJ, Audí C, Castell M, Moretones MG, López-Sabater MC, et al. Effects of cooling and freezing storage on the stability of bioactive factors in human colostrum. J Dairy Sci 2012;95:2319-25. doi: 10.3168/jds.2011-5066, PMID 22541460
Notodihardjo SC, Morimoto N, Kakudo N, Mitsui T, Le TM, Tabata Y, et al. Comparison of the efficacy of cryopreserved human platelet lysate and refrigerated lyophilized human platelet lysate for wound healing. Regen Ther 2019;10:1-9.
Pattison JM, Melo SP, Piekos SN, Torkelson JL, Bashkirova E, Mumbach MR, et al. Retinoic acid and BMP4 cooperate with p63 to alter chromatin dynamics during surface epithelial commitment. Nat Genet 2018;50:1658-65. doi: 10.1038/s41588-018-0263-0, PMID 30397335
Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, et al. p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001;98:3156-61. doi: 10.1073/pnas.061032098, PMID 11248048
Scholzen T, Gerdes J. The Ki-67 protein: From the known and the unknown. J Cell Physiol 2000;182:311-22.
Noszczyk BH, Majewski ST. p63 expression during normal cutaneous wound healing in humans. Plast Reconstr Surg 2001;108:1242-7; discussion 1248. doi: 10.1097/00006534-200110000-00022, PMID 11604626
Li A, Simmons PJ, Pritinder K. Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype. Proc Natl Acad Sci U S A 1998;95:3902-7.
Potten CS, Booth C. Keratinocyte stem cells: A commentary. J Invest Dermatol 2002;199:888-99.
Li A, Pouliot N, Redvers R, Kaur P. Extensive tissue-regenerative capacity of neonatal human keratinocyte stem cells and their progeny. J Clin Invest 2004;113:390-400. doi: 10.1172/JCI19140, PMID 14755336
Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of different wound dressings on cell viability and proliferation. Plast Reconstr Surg 2006;117:110S-8.
Wattanaploy S, Chinaroonchai K, Namviriyachote N, Muangman P. Randomized controlled trial of polyhexanide/betaine gel versus silver sulfadiazine for partial-thickness burn treatment. Int J Low Extrem Wounds 2017;16:45-50. doi: 10.1177/1534734617690949, PMID 28682677
Yang R, Liu F, Wang J, Chen X, Xie J, Xiong K. Epidermal stem cells in wound healing and their clinical applications. Stem Cell Res Ther 2019;10:229.
Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 2007;127:998-1008.
Morasso MI, Tomic-Canic M. Epidermal stem cells: The cradle of epidermal determination, differentiation and wound healing. Biol Cell 2005;97:173-83. doi: 10.1042/BC20040098, PMID 15715523
Yang S, Sun Y, Geng Z, Ma K, Sun X, Fu X. Abnormalities in the basement membrane structure promote basal keratinocytes in the epidermis of hypertrophic scars to adopt a proliferative phenotype. Int J Mol Med 2016;37:1263-73.
Edriss AS, Měšťák J. Epidermal keratinocytes may have an important role in hypertrophic scarring pathogenesis: An immunohistochemical study (using P63 and Ki-67 staining). Ann Burns Fire Disasters 2005;18:133-9. PMID 21990995
Published
How to Cite
Issue
Section
Copyright (c) 2023 Abhishek Adhya, Soumya Gayen, Monoranjan Sow, Kalyan Das, Arindam Sarkar
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
